Zhihang Zhou

机构：City University of Hong Kong, Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, City University of Hong Kong, Shenzhen Research Institute, Qilu Hospital of Shandong University, Chengdu University of Traditional Chinese Medicine, Chongqing Medical University · ORCID：0000-0003-1356-9872

发表论文 120 篇 · 总被引 1662 次 · h-index 22

代表论文

• The Gut‒Liver Axis in Liver Disease: Molecular Mechanisms and Therapeutic Targets (2025 · MedComm · 被引 19)
• Loss of Carbamoyl Phosphate Synthetase 1 Potentiates Hepatocellular Carcinoma Metastasis by Reducing Aspartate Level (2024 · Advanced Science · 被引 19)
• NORAD exacerbates metabolic dysfunction-associated steatotic liver disease development via the miR-511-3p/Rock2 axis and inhibits ubiquitin-mediated degradation of ROCK2 (2024 · Metabolism · 被引 15)
• Magnetic-navigable silk fibroin microneedles for oral drug delivery: Ensuring long-lasting helicobacter pylori eradication and rapid hemostasis in the stomach (2024 · International Journal of Biological Macromolecules · 被引 14)
• Single‐cell sequencing reveals the role of IL‐33 + endothelial subsets in promoting early gastric cancer progression (2025 · iMeta · 被引 10)
• Artificial Plateletoids Recruit Blood Proteins to Shield Symbiotic Thrombin: a Silk Fibroin/Calcium Interface Medicated Thrombin Generation and Preservation (2024 · Small · 被引 8)